Ixazomib Clinical Trials

4 actively recruiting trials across 2 locations

▼ -1 trial since May 2026

Also known as: Ninlaro, Ninlaro®

Pipeline

Phase 2: 1Phase 4: 1Phase 1/2: 2

Top Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University1
Rajshekhar Chakraborty, MD1
Ho Sup Lee1
CellCentric Ltd.1

Indications

Cancer4
Multiple Myeloma2
Higher-risk Myelodysplastic Syndrome1
Peripheral T Cell Lymphoma1
AL Amyloidosis1

Other2 trials

Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Phase 2

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Phase 4

Atlanta, Georgia1 trial

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Emory Winship Cancer Institute

Phase 1/2

Boston, Massachusetts1 trial

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Boston Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.